United States · FDA National Drug Code directory
Oseltamivir Phosphate for Oral Suspension
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 47781-384_bc6ab861-892d-407f-7187-e7a9e31bd593
- Product NDC
- 47781-384
- Form
- POWDER, FOR SUSPENSION
- Composition / generic term
- Oseltamivir Phosphate
- Labeler
- Alvogen Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20171101
- Source listing expiry
- 20261231
Source-listed ingredients
- OSELTAMIVIR PHOSPHATE — 6 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, GLASS in 1 CARTON (47781-384-26) / 60 mL in 1 BOTTLE, GLASS · 47781-384-26
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →